Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes.

Pharmacogenetics - 1 Apr 2000

Miners J O, Coulter S, Birkett D J, Goldstein J A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C9
Share to Cytochrome P-450 Enzyme Inhibitors
Share to Diuretics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Microsomes, Liver

Share to Steroid 16-alpha-Hydroxylase

Share to Steroid Hydroxylases

Share to Sulfonamides

Source

Identifiers

PMID: 10803683
DOI: 10.1097/00008571-200004000-00008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes.PMID 10803683Read ↗

Genetic variation at the CYP2C locus and its association with torsemide biotransformation.Semantic proximity Read ↗

Investigating the contribution of CYP2J2 to ritonavir metabolism in vitro and in vivoSemantic proximity Read ↗

Cytochrome P450 2C9-CYP2C9.Semantic proximity Read ↗

Cytochrome P450 2C8: Substrates, inhibitors, pharmacogenetics, and clinical relevanceSemantic proximity Read ↗

Sex-specific differences in CYP450 isoforms in humans.Semantic proximity Read ↗

Human CYP2C8: structure, substrate specificity, inhibitor selectivity, inducers and polymorphisms.Semantic proximity Read ↗

PharmGKB summary: cytochrome P450, family 2, subfamily J, polypeptide 2: CYP2J2.Semantic proximity Read ↗

CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide.Semantic proximity Read ↗

Drugs as CYP3A Probes, Inducers, and InhibitorsSemantic proximity Read ↗

Biochemistry and molecular biology of the human CYP2C subfamily.Semantic proximity Read ↗

The role of the poor metabolizer genotype CYP2D6 and CYP1A2 phenotype in the pharmacokinetics of duloxetine and venlafaxine-A case report.Semantic proximity Read ↗

CYP2C9 polymorphism: impact on tolbutamide pharmacokinetics and response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.